We compared the PLZF mRNA expression between a normal, primary tumor, and metastatic tumor using the TCGA database, and found that PLZF expression was more decreased in metastatic tumors (Figure 1E). The gene discussed is ZBTB16; the disease is metastatic neoplasm.